The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
Carraz M, Traeger J, Fries D, Perrin J, Saubier E, Brochier J, Veysseyre C, Prevot J, Bryon P, Jouvenceaux A, Archimbaud JP, Bonnet P, Manuel Y, Bernhardt JP, Traeger Fouillet Y. Préparation, proprietet et activite d’immunoglobulines de cheval antilymphocytes humains. Revue de l’Institut Pasteur de Lyon 1967;1:17.
Clunie GJ, Nolan B, James K, Watt JG, Woodruff MF. Prolongation of canine renal allograft survival with antilymphocytic serum.. Transplantation 1968 May;6(3):459-67.
Fateh-Moghadam A, Pichlymayr R, Jarosch von Schweder HW, Knedel M. [Isolation of immunologically active gamma-globulins of a horse-anti-dog lymphocyte serum].. Klin Wochenschr 1967 Jun 1;45(11):578-85.
Henry RJ, Sobel C, Berkman S. Interferences with biuret methods for serum proteins. Use of Benedict’s qualitative glucose reagent as a biuret reagent. Anal. Chem. 1957;29:1491.
Iwasaki Y, Porter KA, Amend JR, Marchioro TL, Zühlke V, Starzl TE. The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions.. Surg Gynecol Obstet 1967 Jan;124(1):1-24.
Kashiwagi N, Groth CG, Amend JR, Gecelter L, Blanchard H, Starzl TE. Improvements in the preparation of heterologous antilymphocyte globulin with special reference to absorption and diethylaminoethyl cellulose batch production.. Surgery 1969 Mar;65(3):477-84.
Mandel MA, Asofsky R. The effects of heterologous anti-thymocyte sera in mice. II. Quantitative evaluation of IgM, IgG, and their subunits in suppressing homograft reactions.. J Immunol 1968 Jun;100(6):1259-67.
Monaco AP, Wood ML, Gray JG, Russell PS. Studies on heterologous anti-lymphocyte serum in mice. II. Effect on the immune response.. J Immunol 1966 Feb;96(2):229-38.
Monaco AP, Wood ML, van der Werf BA, Russell PS. Effects of antilymphocytic serum in mice, dogs, and man. In: Wolstenholme GEW, O’Connor M, editors. Antilymphocytic serum. London: J. & A. Churchill, Ltd.; 1967. pp. 111–134.
Najarian JS, Merkel FK, Moore GE, Good RA, Aust JC. Clinical use of antilymphoblast serum.. Transplant Proc 1969 Mar;1(1):460-2.
Pichlmayr R, Brendel W, Mikaeloff PH, Wiebecke B, Rassat JP, Pichlmayr I, Bomel J, Fateh-Moghadam A, Thierfelder S, Messmer K, Descotes J, Knedel M. Survival of renal and liver homografts in dogs treated with heterologous antilymphocyte serum. In: Dausset J, Hamburger J, Mathe G, editors. Advance in transplantation. Baltimore: The Williams & Wilkins Company; 1968. pp. 147–154.
Pichlmayr R, Brendel W, Tsirimbas A, Bock E, Thierfelder S, Fateh-Moghadam A, Hornung B, Pfisterer H. Use of heterologous antilymphocyte sera in man. J. Cardiov. Surg VIII Congress of the International Cardiovascular Society 1968;57.
Shorter RG, Hallenbeck GA, Nava C, O'Kane H, DeWeerd JH, Johnson WJ. Antilymphoid sera in renal allotransplantation.. Arch Surg 1968 Aug;97(2):323-9.
Starzl TE, Brettschneider L, Penn I, Schmidt RW, Bell P, Kashiwagi N, Townsend CM, Putnam CW. A trial with heterologous antilymphocyte globulin in man.. Transplant Proc 1969 Mar;1(1):448-54.
Thierfelder S, Möller D, Eulitz M, Dörmer P, Kimura I. [Antibody population in heterologous antilymphocyte serum of the rabbit].. Klin Wochenschr 1968 Mar 1;46(5):277-8.
Woodruff MFA. Antilymphocyte serum as an immunosuppressive agent. In: Seiffert KE, Geisendorffer, editors. Transplantation von Organen und Geweben. Stuttgart: Thieme Verlag; 1967. pp. 93–97.
Woodruff MFA, James K, Anderson NF, Reid BL. In vivo and in vitro properties of antilymphocytic serum. In: Wolstenholme GEW, O’Connor M, editors. Antilymphocytic serum. London: J. & A. Churchill, Ltd.; 1967. pp. 57–68.
Citations
This article has been cited 6 times.
Groth CG, Kashiwagi N, Moore GE, Husberg B, Bjorken C, Putnam CW, Starzl TE. Production of a Standardized Anti-Lymphocyte Globulin. Behring Inst Mitt 1972 Sep;51:86-89.
Amemiya H, Yokoyama T, Putnam CW, Torisu M, Starzl TE. The nature of antiplatelet activity in antilymphoblast ALG--with special reference to cross-reacting antibody, immunochemical characterization, and Coombs' positive thrombocytopenia in ALG-treated renal recipients. Clin Exp Immunol 1972 Mar;10(3):417-26.
Starzl TE, Boehmig HJ, Amemiya H, Wilson CB, Dixon FJ, Giles GR, Simpson KM, Halgrimson CG. Clotting changes, including disseminated intravascular coagulation, during rapid renal-homograft rejection. N Engl J Med 1970 Aug 20;283(8):383-90.
Allardyce RA, Anderson NF, Vaerman JP, James K. The antigenic and immunosuppressive properties of normal and antilymphocytic equine IgG subfractions. Clin Exp Immunol 1973 Feb;13(2):263-78.